Carcinoma of the uterine cervix FIGO stage I-B

Leon L. Adcock; Thomas M. Julian; Takashi Okagaki; Thomas K. Jones; Konald A. Prem; Leo B. Twiggs; Roger A. Potish; George L. Phillips

doi:10.1016/0090-8258(82)90090-7

Carcinoma of the uterine cervix FIGO stage I-B

Leon L. Adcock, Thomas M. Julian, Takashi Okagaki, Thomas K. Jones, Konald A. Prem, Leo B. Twiggs, Roger A. Potish, George L. Phillips

Obstetrics & Gynecology

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Abstract

All patients with cervical carcinoma, FIGO Stage I-B, admitted to the Gynecologic Oncology Service of the University of Minnesota Hospitals during the 10-year period ending December 31, 1979, were reviewed. The 5-year survival rate without evidence of disease was 75.3%, the corrected rate being 80.8%. During the last half of the study there was a significant increase in the percentage of patients with adenosquamous carcinoma. The survival rate for younger patients with this diagnosis was significantly lower. Patients frequently had normally interpreted Pap smears in the years just prior to the diagnosis of invasive carcinoma. Early diagnosis of cervical carcinoma is essential. Reliance cannot be placed on a normally interpreted Pap smear, particularly for those patients who have adenosquamous carcinoma or adenocarcinoma.

Original language	English (US)
Pages (from-to)	199-208
Number of pages	10
Journal	Gynecologic oncology
Volume	14
Issue number	2
DOIs	https://doi.org/10.1016/0090-8258(82)90090-7
State	Published - Oct 1982

ASJC Scopus subject areas

Oncology
Obstetrics and Gynecology

Access to Document

10.1016/0090-8258(82)90090-7

Cite this

@article{a17a9ca4d8cf463d88edb67bc955340c,

title = "Carcinoma of the uterine cervix FIGO stage I-B",

abstract = "All patients with cervical carcinoma, FIGO Stage I-B, admitted to the Gynecologic Oncology Service of the University of Minnesota Hospitals during the 10-year period ending December 31, 1979, were reviewed. The 5-year survival rate without evidence of disease was 75.3%, the corrected rate being 80.8%. During the last half of the study there was a significant increase in the percentage of patients with adenosquamous carcinoma. The survival rate for younger patients with this diagnosis was significantly lower. Patients frequently had normally interpreted Pap smears in the years just prior to the diagnosis of invasive carcinoma. Early diagnosis of cervical carcinoma is essential. Reliance cannot be placed on a normally interpreted Pap smear, particularly for those patients who have adenosquamous carcinoma or adenocarcinoma.",

author = "Adcock, {Leon L.} and Julian, {Thomas M.} and Takashi Okagaki and Jones, {Thomas K.} and Prem, {Konald A.} and Twiggs, {Leo B.} and Potish, {Roger A.} and Phillips, {George L.}",

year = "1982",

month = oct,

doi = "10.1016/0090-8258(82)90090-7",

language = "English (US)",

volume = "14",

pages = "199--208",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Academic Press Inc.",

number = "2",

}

TY - JOUR

T1 - Carcinoma of the uterine cervix FIGO stage I-B

AU - Adcock, Leon L.

AU - Julian, Thomas M.

AU - Okagaki, Takashi

AU - Jones, Thomas K.

AU - Prem, Konald A.

AU - Twiggs, Leo B.

AU - Potish, Roger A.

AU - Phillips, George L.

PY - 1982/10

Y1 - 1982/10

N2 - All patients with cervical carcinoma, FIGO Stage I-B, admitted to the Gynecologic Oncology Service of the University of Minnesota Hospitals during the 10-year period ending December 31, 1979, were reviewed. The 5-year survival rate without evidence of disease was 75.3%, the corrected rate being 80.8%. During the last half of the study there was a significant increase in the percentage of patients with adenosquamous carcinoma. The survival rate for younger patients with this diagnosis was significantly lower. Patients frequently had normally interpreted Pap smears in the years just prior to the diagnosis of invasive carcinoma. Early diagnosis of cervical carcinoma is essential. Reliance cannot be placed on a normally interpreted Pap smear, particularly for those patients who have adenosquamous carcinoma or adenocarcinoma.

AB - All patients with cervical carcinoma, FIGO Stage I-B, admitted to the Gynecologic Oncology Service of the University of Minnesota Hospitals during the 10-year period ending December 31, 1979, were reviewed. The 5-year survival rate without evidence of disease was 75.3%, the corrected rate being 80.8%. During the last half of the study there was a significant increase in the percentage of patients with adenosquamous carcinoma. The survival rate for younger patients with this diagnosis was significantly lower. Patients frequently had normally interpreted Pap smears in the years just prior to the diagnosis of invasive carcinoma. Early diagnosis of cervical carcinoma is essential. Reliance cannot be placed on a normally interpreted Pap smear, particularly for those patients who have adenosquamous carcinoma or adenocarcinoma.

UR - http://www.scopus.com/inward/record.url?scp=0019907058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019907058&partnerID=8YFLogxK

U2 - 10.1016/0090-8258(82)90090-7

DO - 10.1016/0090-8258(82)90090-7

M3 - Article

C2 - 7129216

AN - SCOPUS:0019907058

VL - 14

SP - 199

EP - 208

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -

Carcinoma of the uterine cervix FIGO stage I-B

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this